Skip to main content
Ellis Reinherz, MD, Oncology, Boston, MA

EllisLReinherzMD

Oncology Boston, MA

Professor of Medicine, Dana-Farber Cancer Institute

Are you Dr. Reinherz?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 49 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    Dana Farber Cancer Inst.
    44 Binney Street
    Boston, MA 02115
    Phone+1 617-632-3412

Summary

  • Dr. Ellis Reinherz, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Dana-Farber Cancer Institute and is a Professor of Medicine at Dana-Farber Cancer Institute.

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1977 - 1979
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1975 - 1977
  • Harvard Medical School
    Harvard Medical SchoolClass of 1975

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1977 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1988

Publications & Presentations

PubMed

Press Mentions

  • New Study Unveils the Power of Physical Forces in Enhancing T Cell Immune Response
    New Study Unveils the Power of Physical Forces in Enhancing T Cell Immune ResponseAugust 14th, 2024
  • Study Uncovers Key Parts of Mechanism for Activating T Cells to Fight Cancer and Other Diseases
    Study Uncovers Key Parts of Mechanism for Activating T Cells to Fight Cancer and Other DiseasesOctober 30th, 2018
  • Cancer-Fighting T Cells Are Smarter, Stronger Than Experts Thought
    Cancer-Fighting T Cells Are Smarter, Stronger Than Experts ThoughtAugust 11th, 2017

Grant Support

  • Structural Approches To HIV-1 Immunogen Design For Bnab GenerationNational Institute Of Allergy And Infectious Diseases2010–2011
  • Eliciting B Cells To Produce Anti-Hiv GP41 Mper-Specific Neutralizing AntibodiesNational Institute Of Allergy And Infectious Diseases2010–2011
  • Crossprotective CTL Against InfluenzaNational Institute Of Allergy And Infectious Diseases2010–2011
  • Administrative CoreNational Institute Of Allergy And Infectious Diseases2010–2011
  • Structural Approaches To HIV-1 Immunogen Design For Bnab GenerationNational Institute Of Allergy And Infectious Diseases2009–2011
  • T Cell Antigen RecognitionNational Institute Of Allergy And Infectious Diseases2009–2010
  • Protective Orthopox Immunization In Normals And Patients With Cancer Or EczemaNational Institute Of Allergy And Infectious Diseases2007–2009
  • Hivrad: Structural Approaches To Vaccine DevelopmentNational Institute Of Allergy And Infectious Diseases2002–2009
  • Research Resource Technical Development ComponentNational Institute Of Allergy And Infectious Diseases2008
  • Neutralization CoreNational Institute Of Allergy And Infectious Diseases2008
  • Flow Cytometry CoreNational Institute Of Allergy And Infectious Diseases2008
  • Educational ComponentNational Institute Of Allergy And Infectious Diseases2008
  • Biomarkers Of Immunity To Orthopox VirusesNational Institute Of Allergy And Infectious Diseases2008
  • Administrative CoreNational Institute Of Allergy And Infectious Diseases2008
  • Structure-Based Design For Neutralizing Antibodies Against SIV/HIVNational Institute Of Allergy And Infectious Diseases2007–2008
  • Orthopox Immunization In Patients With Cancer Or EczemaNational Institute Of Allergy And Infectious Diseases2003–2008
  • T Cell Antigen RecognitionNational Institute Of Allergy And Infectious Diseases1999–2008
  • Protein ProductionNational Institute Of Allergy And Infectious Diseases2007
  • AdministrativeNational Institute Of Allergy And Infectious Diseases2007
  • Positive Selection Of ThymocytesNational Institute Of Allergy And Infectious Diseases2006
  • Genes Encoding T Cell ReceptorsNational Institute Of Allergy And Infectious Diseases1987–2006
  • Positive Selection Of ThymocytesNational Institute Of Allergy And Infectious Diseases2000–2004
  • Thymic Vaccination: Manipulating The T Cell RepertoireNational Institute Of Allergy And Infectious Diseases2001–2003
  • Structure-Based Design For Nabs Against SIV/HIVNational Institute Of Allergy And Infectious Diseases2002
  • Core--Protein ProductionNational Institute Of Allergy And Infectious Diseases2002
  • Mouse T Cell Receptors Specific For Vesicular Stomatitis Virus &Hiv CD4 StructNational Center For Research Resources1998–2002
  • Core--Flow CytometryNational Cancer Institute1996–2002
  • SIV &Hiv Trimeric Envelope ProteinNational Center For Research Resources1999–2001
  • Structural Analysis Of Cd4-Ligand InteractionsNational Institute Of Allergy And Infectious Diseases1998–2001
  • Novel HIV Therapies--IpcpNational Institute Of Allergy And Infectious Diseases1998–2001
  • Core--Protein Production And AssayNational Institute Of Allergy And Infectious Diseases1998–2001
  • Model 377 DNA Sequencer And AccessoriesNational Center For Research Resources2000
  • Positive Selection Of ThymocytesNational Institute Of Allergy And Infectious Diseases1999
  • Mouse T Cell Receptors Specific For Vesicular Stomatitis Virus &Hiv CD4 StructNational Center For Research Resources1998
  • CD2 Oligomerization Induced By N Linked GlycansNational Center For Research Resources1998
  • Structural Analysis Of The CD4-HIV GP120 InteractionNational Institute Of Allergy And Infectious Diseases1997–1998
  • Core--Protein Production And AssayNational Institute Of Allergy And Infectious Diseases1997–1998
  • National Cooperative Drug Discovery Group--HivNational Institute Of Allergy And Infectious Diseases1994–1998
  • Human T-Cell Antigen Recognition StructuresNational Institute Of Allergy And Infectious Diseases1994–1998
  • Genes Encoding T Cell Receptors: AIDSNational Center For Research Resources1997
  • FACS Vantage Cell SorterNational Center For Research Resources1997
  • Fc-Epsilon-Ri-Gamma In T Cell Receptors On Lgl--FunctionNational Institute Of Allergy And Infectious Diseases1996
  • Genes Encoding T Cell ReceptorsNational Center For Research Resources1996
  • Genes Encoding T-Cell ReceptorsNational Institute Of Allergy And Infectious Diseases1994–1996
  • Structure/Function Analysis Of CallaNational Cancer Institute1994–1995
  • Comprehensive National COOP Drug Discovery Group-AidsNational Institute Of Allergy And Infectious Diseases1988–1993
  • Structure-Function Analysis Of CallaNational Cancer Institute1988–1993
  • Human T Cell Antigen Recognition StructuresNational Institute Of Allergy And Infectious Diseases1988–1992
  • Mechanism Of Cytolytic T Cell And NK Cell FunctionNational Institute Of Allergy And Infectious Diseases1986–1988
  • Human T Cell Antigen-Recognition StructuresNational Institute Of Allergy And Infectious Diseases1985–1987
  • TI A And B V Gene Usage In Human T Cell MalignanciesNational Cancer Institute1985–1987
  • Genes Encoding The T Cell Antigen ReceptorNational Institute Of Allergy And Infectious Diseases1985–1986